Treatment of lower extremity telangiectasias by thermocoagulation method using TS-3000 apparatus

Objective: this paper aims at studying the efficacy of the thermocoagulation (TCG) method using TC-3000 apparatus for the treatment of lower extremity telangiectasias. Materials and methods. The TCG method has been used in 145 patients (223 cases) with telangiectasias (TA) and reticular veins (RV) of the lower extremities for 2 years. 17 patients (11.7%) had classes C1, 2 chronic venous diseases (CHV), and they underwent correction of pathological refluxes in the subcutaneous and perforating veins prior to TCG. Out of 128 patients with class C1 CHV, 25 people (19.5%) underwent microsclerotherapy (MST) in the past, just before the TCG procedure or in combination with it, MST was performed in 46 (35.9%). MST was performed for RV situated outside or within TA areas, and also was performed for TA from 0.6 to 1.0 mm in diameter. The TCG procedures were performed using TC-3000 (Belgium) apparatus, which operation is based on the impact of high-frequency electromagnetic field (4 MHz) on the dilated vessels in the skin. Needles made of nickel with a working diameter of 0.150 mm were used. Thermocoagulation was applied for the treatment of TA with a diameter of 0.3 mm to 0.6 mm. The results were evaluated within the following time-limits: 3 months (64 patients/97 limbs), 6 months (72/110), 12 months (70/107). Results of the treatment. The patients reported the results of the treatment as «no change and worse» in 73.4% of cases, pigmentation was detected in 73.2%, and residual TA in 81.4% of cases 3 months following the treatment. According to subjective assessment, the results were reported as «excellent» + «better» in 47.2%, pigmentation phenomena and residual TA were observed in 50.0% and in 50.9% of cases 6 months following the treatment. According to subjective assessment, the results were reported as «excellent» + «better» in 75.7%, pigmentation in 14.9%, residual TA in 13.1%, relapses TA in 14.0% 12 month following the treatment. Conclusion. 13.1% of patients with TA showed tolerance towards TCG. A positive effect included the absence of registered necrosis of the skin 3 months following the treatment, as well as atrophic and hypertrophic scars 12 months following the treatment.

телеангиэктазии, ретикулярные вены, микросклеротерапия, термокоагуляция, ТС-3000, simultaneous operations combined gynecological and surgical pathology, laparoscopy, stationary substitution technologies, microsclerotherapy

1. RuckLy CV, Evans CJ, Allan PL et al. Telangiectasia in the Edinburgh Vein Study: Epidemiology and Association with Trunk Varices and Symptoms. Eur J Vasc Endovasc Surg, 2008, 36(6): 719-724.

2. Шиманко А.И., Дибиров М.Д., Цуранов C.B. и др. Современные миниинвазивные методики в лечении варикозной болезни. Флебология, 2009, 1(1): 25-29./ Shimanko AI, Dibirov MD, Tsuranov CB. Modern minimally invasive techniques in the treatment of varicose veins. Flebologiya, 2009, 1 (1): 25-29. sclerotherapy in dermatology. Indian J Dermatol Venereol Leprol, 2011, 77 (2): 222-231.

3. Vitale-Lewis VA. Aesthetic Treatment of Leg Veins. Aesthetic Surg. J, 2008, 28 (5): 573-583.

4. Goldman MP. My Sclerotherapy Technique for Telangiectasia and Reticular Veins. Dermatol Surg, 2010, 36(Suppl. s2): 1040-1045.

5. Sadick NS. Choosing the Appropriate Sclerosing Concentration for Vessel Diameter. Dermatol Surg, 2010, 36(Suppl. s2): 976-981.

6. Kern P, Ramelet AA, Wutschert R et al. A Double-Blind, Randomized Study Comparing Pure Chromated Glycerin with Chromated Glycerin with 1% Lidocaine and Epinephrine for Sclerotherapy of Telangiectasias and Reticular Veins. Dermatol Surg, 2011, 37(11): 1590-1594.

7. Willenberg T, Smith P C, Shepherd A et al. Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematicliterature review. Phlebology, 2013, 28(3): 123-131.

8. Guex JJ, Schliephake D, Otto J et al. The French Polidocanol Study on Long-Term Side Effects: A Survey Covering 3,357 Patient Years. Dermatol Surg, 2010, 36(Suppl. s2): 993-1003.

9. Palm MD, Guiha IC, Goldman MP. Foam Sclerotherapy for Reticular Veins and Nontruncal Varicose Veins of the Legs: A Retrospective Review of Outcomes and Adverse Effects. Dermatol Surg, 2010, 36(Suppl. s2): 1026-1033.

10. Бутов Ю. С., Демина О.М. К вопросу о лазерной терапии телеангиэктазий. Российский журнал кожных и венерических болезней, 2 0 0 6, 2 : 53 - 57./ Butov YuS, Demina OM. Revisitinglaser therapy of telangiectasias. Rossiyskiy Zhurnal Kozhnyh i Venericheskih Bolezney, 2006, 2: 53-57.

11. MCCoppin HH, Hovenic WW, Wheeland RG. Laser Treatment of Superficial Leg Veins: A Review. Dermatol Surg, 2011, 37(6): 729-741.

12. Quirke TE, Rauscher G, Heath LL. Laser Treatment of Leg and Facial Telangiectasia. Aesthetic Surg J, 2000, 20(6): 465-470.

13. Баранник М.И., Белянина Е.О. Телеангиэктазии нижних конечностей: сравнительное исследование эффективности чрескожной лазерной коагуляции и микросклеротерапии. Вестник эстетической медицины, 2012, 11(2): 12-21./ Barannik MI, Belyanina EO. Lower extremities telangiectasias: a comparative study of the efficacy of percutaneouslaser coagulation and microscle-rotherapy. Vestnik Esteticheskoy Meditsiny, 2012, 11 (2): 12-21.

14. Levy JL, Elbahr C, Jouve E et al. Comparison and sequential study oflong pulsed Nd-YAG 1064 nmlaser and sclerotherapy inleg telangiectasias treatment. Lasers Surg Med, 2004, 34(4): 273-276.

15. Королькова Т.Н., Игнатюк М.А. Критерии подходов к склерозированию телеангиэктазий нижних конечностей. Вестник дерматологии и венерологии, 2007, 6: 66-69. Korolkova TN, Ignatyuk MA Criteria for sclerosing telangiectasias oflowerlimbs. Herald of Dermatology and Venereology, 2007, 6: 66-69.

16. Шиманко А.И., Дибиров М.Д., Цуранов С.В. и др. Лазерная чрескожная фотокоагуляция телеангиэктазий различной локализации. Флебология, 2008, 2(2): 17-20. / Shimanko AI, Dibirov MD, Tsuranov S.V. Laser percutaneous photocoagulation of telangiectasias of variouslocalization. Flebologiya, 2008, 2 (2): 17-20.

17. Королькова Т.Н., Игнатюк М.А., Баллюзек Ф.В и др. Сравнительный анализ эффективности современных средств склерозирования телеангиэктазий нижних конечностей. Российский журнал кожных и венерических болезней, 2007, 3: 39-42. /Korolkova TN, Ignatyuk MA, Balliusek FV, et al. A comparative analysis of the efficacy of modern sclerosing solutions forlower extremity telangiectasias. Rossiyskiy Zhurnal Kozhnyh i Venericheskih Bolezney, 2007, 3: 39-42.

18. Bush RG, Shamma HN, Hammond K. Histological changes occurring after endoluminal ablation with two diodelasers (940 and 1319 nm) from acute changes to 4 months. Lasers Surg Med, 2008, 40(10): 676-679.

19. Chardonneau JM. Termocoagulation: efficacite dela premiere seance surles teleangiectasies des membres inferieurs. Etude sur 30 patients. Phlebologie, 2006, 59(4): 329-331.

20. Efficacy and results of thermocoagulation modality in the treatment of reticular and telengiestatic veins:midterm andlongterm results of 5000 cases [Electronic resource]. URL: 22. http://www.fcaresystems.com/wp-content/ uploads/2012/11/TC3000-Clinical-Study-on-5000-patients.pdf. - 04.09.2015.